Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ALBEMARLE CORPALB · Entity 2581 | Chief Commercial Officer | September 14, 2026 | September 16, 2026 |
| FMC CORPFMC · Entity 4704 | President Health Nutrition | May 16, 2017 | May 18, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ALBEMARLE CORP
Report date September 14, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 64,310 |
Reported balance
After 2026-09-14 transaction · row 1
1 source rowRow 1 · 2026-09-14 · Grant · Acquired 10,867 · Balance 64,310 F1: Restricted Stock Units that vest 100% on 03/14/2028, subject to the terms of the award agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units that vest 100% on 03/14/2028, subject to the terms of the award agreement.
FMC CORP
Report date May 16, 2017 · Filed May 18, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,320 |
Ending reported balance
After 2017-05-17 transaction · row 8
8 source rows · reconciled sequenceRow 1 · 2017-05-16 · Exercise / conversion · Acquired 2,642 · Balance 28,750 Row 2 · 2017-05-16 · Exercise / conversion · Acquired 2,484 · Balance 31,234 Row 3 · 2017-05-16 · Exercise / conversion · Acquired 3,444 · Balance 34,678 Row 4 · 2017-05-16 · Sale · Disposed 2,642 · Balance 32,036 F1: Represents the weighted average sales price for price increments ranging from $75.951 to $75.968. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Row 5 · 2017-05-16 · Sale · Disposed 2,484 · Balance 29,552 F2: Represents the weighted average sales price for price increments ranging from $75.950 to $75.960. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Row 6 · 2017-05-16 · Sale · Disposed 3,444 · Balance 26,108 Row 7 · 2017-05-16 · Sale · Disposed 1,494 · Balance 24,614 F3: Represents the weighted average sales price for price increments ranging from $75.826 to $75.871. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Row 8 · 2017-05-17 · Sale · Disposed 1,294 · Balance 23,320 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.89 · Expires 2021-02-17 | Direct | 0 |
Reported balance
After 2017-05-16 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2017-05-16 · Exercise / conversion · Disposed 2,642 · Balance 0 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.60 · Expires 2022-02-16 | Direct | 0 |
Reported balance
After 2017-05-16 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2017-05-16 · Exercise / conversion · Disposed 2,484 · Balance 0 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $59.47 · Expires 2023-02-18 | Direct | 0 |
Reported balance
After 2017-05-16 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2017-05-16 · Exercise / conversion · Disposed 3,444 · Balance 0 |
| Common StockSEC Table I · non-derivative | IndirectThrift Plan | 6,288.437 |
Reported balance
Holding disclosure · report date 2017-05-16 · row 9
Holding and transaction disclosures are not merged.
1 source rowRow 9 · Balance 6,288.437 F4: Based on plan statement as of May 16, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the weighted average sales price for price increments ranging from $75.951 to $75.968. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
F2: Represents the weighted average sales price for price increments ranging from $75.950 to $75.960. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
F3: Represents the weighted average sales price for price increments ranging from $75.826 to $75.871. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
F4: Based on plan statement as of May 16, 2017.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2017 Filed May 18, 2017 19:26 UTC | FMC CORP FMC · Entity 4704 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,484 | $0.00 Strike: $47.60 | $0.00 |
DisclosureSEC source: 0001127602-17-018621 · form4.xml · derivative · entry 11 Norris Eric · CIK 0001624621 · President Health Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,484 shares Expires 2022-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2017 Filed May 18, 2017 19:26 UTC | FMC CORP FMC · Entity 4704 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,642 | $0.00 Strike: $40.89 | $0.00 |
DisclosureSEC source: 0001127602-17-018621 · form4.xml · derivative · entry 10 Norris Eric · CIK 0001624621 · President Health Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,642 shares Expires 2021-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2017 Filed May 18, 2017 19:26 UTC | FMC CORP FMC · Entity 4704 | SaleCommon Stock | 1,494 | $75.84 | $113,303.47 |
DisclosureSEC source: 0001127602-17-018621 · form4.xml · nonDerivative · entry 7 Norris Eric · CIK 0001624621 · President Health Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,614 F3 · price: Represents the weighted average sales price for price increments ranging from $75.826 to $75.871. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| May 16, 2017 Filed May 18, 2017 19:26 UTC | FMC CORP FMC · Entity 4704 | SaleCommon Stock | 3,444 | $75.96 | $261,599.35 |
DisclosureSEC source: 0001127602-17-018621 · form4.xml · nonDerivative · entry 6 Norris Eric · CIK 0001624621 · President Health Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,108 Read SEC document |
| May 16, 2017 Filed May 18, 2017 19:26 UTC | FMC CORP FMC · Entity 4704 | SaleCommon Stock | 2,484 | $75.95 | $188,667.25 |
DisclosureSEC source: 0001127602-17-018621 · form4.xml · nonDerivative · entry 5 Norris Eric · CIK 0001624621 · President Health Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,552 F2 · price: Represents the weighted average sales price for price increments ranging from $75.950 to $75.960. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| May 16, 2017 Filed May 18, 2017 19:26 UTC | FMC CORP FMC · Entity 4704 | SaleCommon Stock | 2,642 | $75.96 | $200,688.96 |
DisclosureSEC source: 0001127602-17-018621 · form4.xml · nonDerivative · entry 4 Norris Eric · CIK 0001624621 · President Health Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,036 F1 · price: Represents the weighted average sales price for price increments ranging from $75.951 to $75.968. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| May 16, 2017 Filed May 18, 2017 19:26 UTC | FMC CORP FMC · Entity 4704 | Exercise / conversionCommon Stock | 3,444 | $59.47 | $204,814.68 |
DisclosureSEC source: 0001127602-17-018621 · form4.xml · nonDerivative · entry 3 Norris Eric · CIK 0001624621 · President Health Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2017 Filed May 18, 2017 19:26 UTC | FMC CORP FMC · Entity 4704 | Exercise / conversionCommon Stock | 2,484 | $47.60 | $118,225.98 |
DisclosureSEC source: 0001127602-17-018621 · form4.xml · nonDerivative · entry 2 Norris Eric · CIK 0001624621 · President Health Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2017 Filed May 18, 2017 19:26 UTC | FMC CORP FMC · Entity 4704 | Exercise / conversionCommon Stock | 2,642 | $40.89 | $108,018.17 |
DisclosureSEC source: 0001127602-17-018621 · form4.xml · nonDerivative · entry 1 Norris Eric · CIK 0001624621 · President Health Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:19 UTC | FMC CORP FMC · Entity 4704 | GrantStock Option (Right to Buy) · Derivative | 7,725 | $0.00 Strike: $57.63 | $0.00 |
DisclosureSEC source: 0001127602-17-009257 · form4.xml · derivative · entry 6 Norris Eric · CIK 0001624621 · VP Gl Bus Dir Health Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,725 Underlying: Common Stock · 7,725 shares Expires 2027-02-27 Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:19 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 25 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009257 · form4.xml · nonDerivative · entry 4 Norris Eric · CIK 0001624621 · VP Gl Bus Dir Health Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,108 F1 · shares: These shares were issued pursuant to dividend equivalent rights accrued with respect to performance based restricted stock units that were "banked" as of this date. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:19 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 2,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009257 · form4.xml · nonDerivative · entry 3 Norris Eric · CIK 0001624621 · VP Gl Bus Dir Health Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,083 Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:19 UTC | FMC CORP FMC · Entity 4704 | GrantCommon Stock | 2,097 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009257 · form4.xml · nonDerivative · entry 2 Norris Eric · CIK 0001624621 · VP Gl Bus Dir Health Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,011 Read SEC document |
| February 17, 2017 Filed Mar 1, 2017 21:19 UTC | FMC CORP FMC · Entity 4704 | Tax withholdingCommon Stock | 447 | $57.83 | $25,850.01 |
DisclosureSEC source: 0001127602-17-009257 · form4.xml · nonDerivative · entry 1 Norris Eric · CIK 0001624621 · VP Gl Bus Dir Health Nutrition 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,914 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.